Literature DB >> 15003718

1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility.

Brad R Henke1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003718     DOI: 10.1016/S0079-6468(04)42001-3

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


× No keyword cloud information.
  6 in total

1.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

2.  Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia.

Authors:  Puneet Rinwa; Baljinder Kaur; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-06       Impact factor: 3.000

Review 3.  Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models.

Authors:  David T Stark; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2011-03-10       Impact factor: 5.590

4.  Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.

Authors:  Yuhai Zhao; Frederic Calon; Carl Julien; Jeremy W Winkler; Nicos A Petasis; Walter J Lukiw; Nicolas G Bazan
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

5.  ADDP and PS-PPh3: an efficient Mitsunobu protocol for the preparation of pyridine ether PPAR agonists.

Authors:  Paul S Humphries; Quyen-Quyen T Do; David M Wilhite
Journal:  Beilstein J Org Chem       Date:  2006-10-31       Impact factor: 2.883

Review 6.  Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity.

Authors:  Xiao-Rong Peng; Peter Gennemark; Gavin O'Mahony; Stefano Bartesaghi
Journal:  Front Endocrinol (Lausanne)       Date:  2015-11-19       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.